Work

Effects of senolytic drugs on glucose homeostasis, adiposity and hepatic steatosis in obese, diabetic and aged rodents: a systematic review and meta-analysis

Year: 2026
Type: study-registration
Abstract: Protocol of a systematic review and meta-analysis of controlled in vivo rodent studies testing whether senolytic drugs (dasatinib plus quercetin, dasatinib, navitoclax/ABT-263, ABT-737, A-1331852, A-1155463, UBX0101, FOXO4-DRI, 17-DMAG, piperlongumine and other agents explicitly tested as senolytics), compared with vehicle, improve glucose tolerance, insulin tolerance, adiposity and hepatic steatosis in diet-induced obese, genetically obese or diabetic, streptozotocin-diabetic, MASLD/MASH and naturally aged mice and rats. Genetic senescent-cell clearance models form a separate, pre-specified comparison arm. Searches of MEDLINE (PubMed), Web of Science Core Collection and Scopus were completed on 31 October 2026 (3,497 records; 1,968 unique). Screening, data extraction, risk-of-bias assessment (SYRCLE) and analysis (three-level random-effects meta-analysis, Hedges' g) have not started. Companion review: Effects of natural flavonoids and related dietary polyphenols on tissue senescence (https://osf.io/czpef). Reviewers: Irem Alkan (Burdur Mehmet Akif Ersoy University) and Mehmet Albayrak (Isparta University of Applied Sciences).
Language: English
Subfield: Cell Biology
Open Access status: green
OpenAlex ID: W7225050113
Cites:
Cited by:
Related to: 10